CoChat

SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism

Open access

Published version of a preprint

The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.

Abstract

Background: Cancer cells are characterized by uncontrolled cell proliferation and impaired bioenergetics. Sirtuins are a family of highly conserved enzymes that play a fundamental role in energy metabolism regulation. SIRT1, in particular, drives many physiological stress responses and metabolic pathways following nutrient deprivation. We previously showed that SIRT1 activation using SCIC2.1 was able to attenuate genotoxic response and senescence. Here, we report that in hepatocellular carcinoma (HCC) cells under glucose-deprived conditions, SCIC2.1 treatment induced overexpression of SIRT1, SIRT3, and SIRT6, modulating metabolic response. Methods: Flow cytometry was used to analyze the cell cycle. The MTT assay and xCELLigence system were used to measure cell viability and proliferation. In vitro enzymatic assays were carried out as directed by the manufacturer, and the absorbance was measured with an automated Infinite M1000 reader. Western blotting and immunoprecipitation were used to evaluate the expression of various proteins described in this study. The relative expression of genes was studied using real-time PCR. We employed a Seahorse XF24 Analyzer to determine the metabolic state of the cells. Oil Red O staining was used to measure lipid accumulation. Results: SCIC2.1 significantly promoted mitochondrial biogenesis via the AMPK-p53-PGC1α pathway and enhanced mitochondrial ATP production under glucose deprivation. SIRT1 inhibition by Ex-527 further supported our hypothesis that metabolic effects are dependent on SIRT1 activation. Interestingly, SCIC2.1 reprogrammed glucose metabolism and fatty acid oxidation for bioenergetic circuits by repressing de novo lipogenesis. In addition, SCIC2.1-mediated SIRT1 activation strongly modulated antioxidant response through SIRT3 activation, and p53-dependent stress response via indirect recruitment of SIRT6. Conclusion: Our results show that SCIC2.1 is able to promote energy homeostasis, attenuating metabolic stress under glucose deprivation via activation of SIRT1. These findings shed light on the metabolic action of SIRT1 in the pathogenesis of HCC and may help determine future therapies for this and, possibly, other metabolic diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12967-023-04440-9

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 SIRT1 activation does not affect cell cycle progression or cell proliferation and rescues cells from genotoxic stress. a Effects of SIRT1 activators on cell cycle progression of HepG2 cells treated with SRT1720 (5 µM), SCIC2 (50 µM), and SCIC2.1 (25 µM) for 24 h. b Percentage of cells in pre-G1 phase. c and d MTT assay on HepG2 and HaCaT cell lines treated with different concentrations of SCIC2.1 for 24 h and 48 h. e and f Western blot analysis on HepG2 and AC16 cells pretreated with the genotoxic drug DOXO (0.5 µM) for 12 h, and then with Ex-527 (5 µM), SRT1720 (5 µM), and SCIC2 and SCIC2.1 (50 µM and 25 µM, respectively) for 6 h. Heat map showing quantification of p53/p53K382ac bands determined by ImageJ software. Error bars represent the standard deviation (SD) of three biological replicates
Fig. 1 SIRT1 activation does not affect cell cycle progression or cell proliferation and rescues cells from genotoxic stress. a Effects of SIRT1 activators on cell cycle progression of HepG2 cells treated with SRT1720 (5 µM), SCIC2 (50 µM), and SCIC2.1 (25 µM) for 24 h. b Percentage of cells in pre-G1 phase. c and d MTT assay on HepG2 and HaCaT cell lines treated with different concentrations of SCIC2.1 for 24 h and 48 h. e and f Western blot analysis on HepG2 and AC16 cells pretreated with the genotoxic drug DOXO (0.5 µM) for 12 h, and then with Ex-527 (5 µM), SRT1720 (5 µM), and SCIC2 and SCIC2.1 (50 µM and 25 µM, respectively) for 6 h. Heat map showing quantification of p53/p53K382ac bands determined by ImageJ software. Error bars represent the standard deviation (SD) of three biological replicatesCC BY · PubMed Central
Fig. 2 SCIC2.1 increases SIRT1 expression upon glucose deprivation and binds to SIRT1. a Western blot analysis of SIRT1 expression in HepG2 cells treated with SCIC2 (50 µM), SCIC2.1 (25 µM), and Ex-527 (5 µM) for 12 h and 24 h under different concentrations of glucose. Heat map showing quantification of SIRT1 bands determined by ImageJ software. b CETSA assay performed on HepG2 cells treated with SCIC2.1 at 25 µM and the western blot analyses showing SIRT1 protein expression. Heat map showing quantification of SIRT1 bands determined by ImageJ software. c SIRT1 protein expression on HepG2 cells treated with SCIC2.1 (25 µM) and Ex-527 (5 µM) at the indicated time points under low-glucose deprivation. Heat map showing band quantification of SIRT1 protein expression determined by ImageJ software. d SIRT1 mRNA fold expression in HepG2 cells after treatment with SCIC2.1 and Ex-527 for the indicated times. Error bars represent the SD of three biological replicates. Statistical significance was calculated using the student t-test or one-way ANOVA using GraphPad Prism 9.4.0, and statistical significance is expressed as *p-value < 0.05, ***pvalue < 0.001, ****p-value < 0.0001 vs control
Fig. 2 SCIC2.1 increases SIRT1 expression upon glucose deprivation and binds to SIRT1. a Western blot analysis of SIRT1 expression in HepG2 cells treated with SCIC2 (50 µM), SCIC2.1 (25 µM), and Ex-527 (5 µM) for 12 h and 24 h under different concentrations of glucose. Heat map showing quantification of SIRT1 bands determined by ImageJ software. b CETSA assay performed on HepG2 cells treated with SCIC2.1 at 25 µM and the western blot analyses showing SIRT1 protein expression. Heat map showing quantification of SIRT1 bands determined by ImageJ software. c SIRT1 protein expression on HepG2 cells treated with SCIC2.1 (25 µM) and Ex-527 (5 µM) at the indicated time points under low-glucose deprivation. Heat map showing band quantification of SIRT1 protein expression determined by ImageJ software. d SIRT1 mRNA fold expression in HepG2 cells after treatment with SCIC2.1 and Ex-527 for the indicated times. Error bars represent the SD of three biological replicates. Statistical significance was calculated using the student t-test or one-way ANOVA using GraphPad Prism 9.4.0, and statistical significance is expressed as *p-value < 0.05, ***pvalue < 0.001, ****p-value < 0.0001 vs controlCC BY · PubMed Central
Fig. 3 SIRT1 activation by SCIC2.1 significantly increases mitochondrial functions through the AMPK-p53-PGC1α axis upon glucose deprivation. a Western blot analysis of pAMPK (Thr183/172), p53K382ac, p53, PGC1α, and SIRT3 in HepG2 cells treated with SCIC2.1 and Ex-527 at the indicated concentrations and time points. Heat map showing band quantification of protein expression. c CETSA assay performed on HepG2 cells treated with SCIC2.1 at 25 µM and the western blot analyses showing SIRT3 protein expression. Heat map showing quantification of SIRT1 bands determined by ImageJ software. Heat map showing quantification of SIRT 3 bands determined by ImageJ software. d Immunoblots showing the expression of PGC1α, acetyl-lysine and SIRT1 after the treatment with SCIC2.1 (25 µM) at indicated time points. e SIRT3 mRNA fold expression and f PGC1α mRNA fold expression evaluated after the treatment with SCIC2.1 and Ex-527 at the indicated time points. Error bars represent the SD of three biological replicates Statistical significance was calculated using the student t-test or one-way ANOVA using GraphPad Prism 9.4.0, and statistical significance is expressed as *p-value < 0.05, nsp-value > 0.05 vs control
Fig. 3 SIRT1 activation by SCIC2.1 significantly increases mitochondrial functions through the AMPK-p53-PGC1α axis upon glucose deprivation. a Western blot analysis of pAMPK (Thr183/172), p53K382ac, p53, PGC1α, and SIRT3 in HepG2 cells treated with SCIC2.1 and Ex-527 at the indicated concentrations and time points. Heat map showing band quantification of protein expression. c CETSA assay performed on HepG2 cells treated with SCIC2.1 at 25 µM and the western blot analyses showing SIRT3 protein expression. Heat map showing quantification of SIRT1 bands determined by ImageJ software. Heat map showing quantification of SIRT 3 bands determined by ImageJ software. d Immunoblots showing the expression of PGC1α, acetyl-lysine and SIRT1 after the treatment with SCIC2.1 (25 µM) at indicated time points. e SIRT3 mRNA fold expression and f PGC1α mRNA fold expression evaluated after the treatment with SCIC2.1 and Ex-527 at the indicated time points. Error bars represent the SD of three biological replicates Statistical significance was calculated using the student t-test or one-way ANOVA using GraphPad Prism 9.4.0, and statistical significance is expressed as *p-value < 0.05, nsp-value > 0.05 vs controlCC BY · PubMed Central
Fig. 4 SIRT1 activation by SCIC2.1 promotes ATP production and antioxidant response upon glucose starvation. Mitochondrial respiratory parameters following glucose deprivation and bioenergetic parameters associated with SCIC2.1 treatment, and oxygen consumption rate (OCR) of HepG2 cells: a Glucose (25 mM) exposure followed by the treatment with SCIC2.1. b Glucose (5 mM) exposure followed by treatment with SCIC2.1. Histograms show the different parameters (ATP Production, Maximal Respiration, Spare Respiratory Capacity). c Western blot analysis of FOXO3a, NOX2, UCP2, and SOD2 performed in HepG2 cells treated with SCIC2.1 and Ex-527 at the indicated concentrations and time points. Heat map showing band quantification of protein expression determined by ImageJ software. Error bars represent the SD of three biological replicates. Statistical significance was calculated using the student t-test or one-way ANOVA using GraphPad Prism 9.4.0, and statistical significance is expressed as *p-value < 0.05, **p-value < 0.01, and ***p-value < 0.001 vs control.
Fig. 4 SIRT1 activation by SCIC2.1 promotes ATP production and antioxidant response upon glucose starvation. Mitochondrial respiratory parameters following glucose deprivation and bioenergetic parameters associated with SCIC2.1 treatment, and oxygen consumption rate (OCR) of HepG2 cells: a Glucose (25 mM) exposure followed by the treatment with SCIC2.1. b Glucose (5 mM) exposure followed by treatment with SCIC2.1. Histograms show the different parameters (ATP Production, Maximal Respiration, Spare Respiratory Capacity). c Western blot analysis of FOXO3a, NOX2, UCP2, and SOD2 performed in HepG2 cells treated with SCIC2.1 and Ex-527 at the indicated concentrations and time points. Heat map showing band quantification of protein expression determined by ImageJ software. Error bars represent the SD of three biological replicates. Statistical significance was calculated using the student t-test or one-way ANOVA using GraphPad Prism 9.4.0, and statistical significance is expressed as *p-value < 0.05, **p-value < 0.01, and ***p-value < 0.001 vs control.CC BY · PubMed Central
Fig. 5 SCIC2.1 alters the metabolic program and inhibits lipogenesis upon glucose starvation. Extracellular acidification Rate (ECAR) of HepG2. a Glucose (25 mM) exposure followed by the treatment of SCIC2.1 b Glucose (5 mM) exposure followed by the treatment of SCIC2.1. c Western blot analyses of SCIC2.1 alters the metabolic program upon glucose starvation: Western blot analyses p-ACC (Ser79), ACC, PDH, and LDHA was performed in HepG2 cells treated with SCIC2.1 and Ex-527 at indicated concentration and time points. Heat map showing the band quantification of protein expression. d quantification of Oil Red Oil staining at 540 nm (n = 3) using TECAN in HepG2 cells treated with SCIC2.1 and Ex-527 at indicated time points. e Heat map showing different expression levels of genes involved in glycolysis and lipid metabolism in HepG2 cells treated with SCIC2.1 at 25 µM. Statistical significance was calculated using the student t-test or one-way ANOVA using GraphPad Prism 9.4.0, and statistical significance is expressed as *p-value < 0.05, **p-value < 0.01, and ****pvalue < 0.0001 vs control. Error bars represent the standard deviation (SD) of three biological replicates
Fig. 5 SCIC2.1 alters the metabolic program and inhibits lipogenesis upon glucose starvation. Extracellular acidification Rate (ECAR) of HepG2. a Glucose (25 mM) exposure followed by the treatment of SCIC2.1 b Glucose (5 mM) exposure followed by the treatment of SCIC2.1. c Western blot analyses of SCIC2.1 alters the metabolic program upon glucose starvation: Western blot analyses p-ACC (Ser79), ACC, PDH, and LDHA was performed in HepG2 cells treated with SCIC2.1 and Ex-527 at indicated concentration and time points. Heat map showing the band quantification of protein expression. d quantification of Oil Red Oil staining at 540 nm (n = 3) using TECAN in HepG2 cells treated with SCIC2.1 and Ex-527 at indicated time points. e Heat map showing different expression levels of genes involved in glycolysis and lipid metabolism in HepG2 cells treated with SCIC2.1 at 25 µM. Statistical significance was calculated using the student t-test or one-way ANOVA using GraphPad Prism 9.4.0, and statistical significance is expressed as *p-value < 0.05, **p-value < 0.01, and ****pvalue < 0.0001 vs control. Error bars represent the standard deviation (SD) of three biological replicatesCC BY · PubMed Central
Fig. 6 SCIC2.1 indirectly activates SIRT6 and rescues cells from metabolic stress. a Western blot analysis of SIRT6, PUMA, p21, and Bax performed in HepG2 cells treated with SCIC2.1 and Ex-527 at the indicated concentrations and time points. Heat map showing band quantification of protein expression. b SIRT6 mRNA fold expression evaluated after treatment with SCIC2.1 and Ex-527 at the indicated time points. c CETSA assay performed on HepG2 cells treated with SCIC2.1 (25 µM) and SIRT6 protein expression was analyzed. Heat map shows quantification of SIRT6 bands determined by ImageJ software. Statistical significance was calculated using the student t-test or one-way ANOVA using GraphPad Prism 9.4.0, and statistical significance is expressed as *p-value < 0.05, nsp-value > 0.05 vs control. Error bars represent the standard deviation (SD) of three biological replicates
Fig. 6 SCIC2.1 indirectly activates SIRT6 and rescues cells from metabolic stress. a Western blot analysis of SIRT6, PUMA, p21, and Bax performed in HepG2 cells treated with SCIC2.1 and Ex-527 at the indicated concentrations and time points. Heat map showing band quantification of protein expression. b SIRT6 mRNA fold expression evaluated after treatment with SCIC2.1 and Ex-527 at the indicated time points. c CETSA assay performed on HepG2 cells treated with SCIC2.1 (25 µM) and SIRT6 protein expression was analyzed. Heat map shows quantification of SIRT6 bands determined by ImageJ software. Statistical significance was calculated using the student t-test or one-way ANOVA using GraphPad Prism 9.4.0, and statistical significance is expressed as *p-value < 0.05, nsp-value > 0.05 vs control. Error bars represent the standard deviation (SD) of three biological replicatesCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 31

Metadata

Authors
Varghese, B., Chianese, U., Capasso, L., Sian, V., Bontempo, P., Conte, M., Benedetti, R., Altucci, L., Carafa, V., & Nebbioso, A.
Affiliations
University of Campania "Luigi Vanvitelli" (IT)
Corresponding author
  • Altucci, Lucia
  • Nebbioso, Angela
Venue
Journal of Translational Medicine
Published
2023-09-15
Volume
21
Issue
1
Pages
627-627
ISSN
1479-5876 (ISSN-L)
OpenAlex
W4386763081
Cited by
31
References
59
Citations by year
2026: 7 · 2025: 10 · 2024: 12 · 2023: 2
FWCI
4.60
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Translational Medicine (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
Funders
  • PRIN2020 (CW39SJ)
  • ANTHEM (CUPB53C22006540001)
  • PNRR (M6/C2)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
SIRT1, hepatocellular carcinoma, glucose deprivation, energy homeostasis, mitochondrial biogenesis, SIRT3, SIRT6, fatty acid oxidation, de novo lipogenesis, antioxidant response, cancer metabolism, EX527, lipid accumulation
MeSH terms
Carcinoma, Hepatocellular, Homeostasis, Humans, Liver Neoplasms, Tumor Suppressor Protein p53, Sirtuins, Sirtuin 1, Sirtuin 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism. https://app.cochat.ai/papers/10.1186/s12967-023-04440-9
The paper
Varghese, B., Chianese, U., Capasso, L., Sian, V., Bontempo, P., Conte, M., Benedetti, R., Altucci, L., Carafa, V., & Nebbioso, A. (2023). SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism. Journal of Translational Medicine. https://doi.org/10.1186/s12967-023-04440-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.